New Therapies for Acute Myocardial Infarction: Current State of Research and Future Promise

References

• Mozaffarian D , BenjaminEJ, GoASet al. Heart disease and stroke statistics-2016 update: a report from the American Heart Association . Circulation133 ( 4 ), e38 – e360 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Thygesen K , AlpertJS, JaffeASet al. Third universal definition of myocardial infarction . Eur. Heart J.33 ( 20 ), 2551 – 2567 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Windecker S , KolhP, AlfonsoFet al. 2014 ESC/EACTS guidelines on myocardial revascularization . Eur. Heart J.35 ( 37 ), 2541 – 2619 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Ishii H , AmanoT, MatsubaraT, MuroharaT . Pharmacological intervention for prevention of left ventricular remodeling and improving prognosis in myocardial infarction . Circulation118 ( 25 ), 2710 – 2718 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Pfeffer MA , McMurrayJJ, VelazquezEJet al. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both . N. Engl. J. Med.349 ( 20 ), 1893 – 1906 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Gombozhapova A , RogovskayaY, ShurupovVet al. Macrophage activation and polarization in post-infarction cardiac remodelling . J. Biomed. Sci.24 ( 1 ), 13 ( 2017 ).
   PubMedGoogle Scholar
• Jugdutt BI . Ventricular remodeling after infarction and the extracellular collagen matrix: when is enough enough?Circulation108 ( 11 ), 1395 – 1403 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Roncalli J . An update on primary findings and new designs in biotherapy studies for acute myocardial infarction . Future Cardiol.10 ( 6 ), 781 – 788 ( 2014 ).
   PubMedGoogle Scholar
• Moens AL , ClaeysMJ, TimmermansJP, VrintsCJ . Myocardial ischemia/reperfusion-injury, a clinical view on a complex pathophysiological process . Int. J. Cardiol.100 ( 2 ), 179 – 190 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Kloner RA . Does reperfusion injury exist in humans?J. Am. Coll. Cardiol.21 ( 2 ), 537 – 545 ( 1993 ).
   PubMed Web of Science ®Google Scholar
• Zhao ZQ , Vinten-JohansenJ . Myocardial apoptosis and ischemic preconditioning . Cardiovasc. Res.55 ( 3 ), 438 – 455 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Bernardi P . The mitochondrial permeability transition pore: a mystery solved?Front. Physiol.4, 95 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Javadof S , JangS, Parodi-RullánR, KhuchuaZ, KuznetsovAV . Mitochondrial permeability transition in cardiac ischemia-reperfusion: whether cyclophilin D is a viable target for cardioprotection?Cell. Mol. Life Sci.74, 2795 – 2813 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• Zhao ZQ , CorveraJS, HalkosMEet al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning . Am. J. Physiol. Heart Circ. Physiol.285 ( 2 ), H579 – H588 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Kübler W , HaassM . Cardioprotection: definition, classification, and fundamental principles . Heart75 ( 4 ), 330 – 333 ( 1996 ).
   PubMed Web of Science ®Google Scholar
• Hausenloy DJ , BarrabesJA, B⊘tkerHEet al. Ischaemic conditioning and targeting reperfusion injury: a 30 year voyage of discovery . Basic Res. Cardiol.111 ( 6 ), 70 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Tsang A , HausenloyDJ, MocanuMM, YellonDM . Postconditioning: a form of ‘modified reperfusion’ protects the myocardium by activating the phosphatidylinositol 3-kinase-Akt pathway . Circ. Res.95 ( 3 ), 230 – 232 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Lacerda L , SomersS, OpieLH, LecourS . Ischaemic postconditioning protects against reperfusion injury via the SAFE pathway . Cardiovasc. Res.84 ( 2 ), 201 – 208 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Staat P , RioufolG, PiotCet al. Postconditioning the human heart . Circulation112 ( 14 ), 2143 – 2148 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Engsrtom T , KelbækH, HelqvistSet al. Effect of ischemic postconditioning during primary percutaneous coronary intervention for patients with ST-segment elevation myocardial infarction: a randomized clinical trial . JAMA Cardiol.2, 490 – 497 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• Eitel I , StiermaierT, RommelKPet al. Cardioprotection by combined intrahospital remote ischaemic perconditioning and postconditioning in ST-elevation myocardial infarction: the randomized LIPSIA CONDITIONING trial . Eur. Heart J.36 ( 44 ), 3049 – 3057 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Basso E , FanteL, FowlkesJ, PetronilliV, ForteMA, BernardiP . Properties of the permeability transition pore in mitochondria devoid of Cyclophilin D . J. Biol. Chem.280 ( 19 ), 18558 – 18561 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Oka N , WangL, MiW, ZhuW, HonjoO, CaldaroneCA . Cyclosporine A prevents apoptosis-related mitochondiral dysunction after neonatal cardioplegic arrest . J. Thorac. Cardiovasc. Surg.135 ( 1 ), 123 – 130 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Cung TT , MorelO, CaylaGet al. Cyclosporine before PCI in patients with acute myocardial infarction . N. Engl. J. Med.373, 1021 – 1031 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Piot C , CroisilleP, StaatPet al. Effect of cyclosporine on reperfusion injury in acute myocardial infarction . N. Engl. J. Med.359 ( 5 ), 473 – 481 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Ottani F , LatiniR, StaszewskyLet al. Cyclosporine A in reperfused myocardial infarction: the multicenter, controlled, open-label CYCLE trial . J. Am. Coll. Cardiol.67 ( 4 ), 365 – 374 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Chen-Scarabelli C , ScarabelliTM . Cyclosporine A prior to primary PCI in STEMI patients: the Coup de Grâce to post-conditioning?J. Am. Coll. Cardiol.67 ( 4 ), 375 – 378 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Bolognese L , NeskovicAN, ParodiGet al. Left ventricular remodeling after primary coronary angioplasty: patterns of left ventricular dilatation and long term prognostic implications . Circulation106 ( 18 ), 2351 – 2357 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Savoye C , EquineO, TricotOet al. Left ventricular remodeling after anterior acute myocardial infarction in modern clinical practice (from the Remodelage Ventriculaire [REVE] Study Group) . Am. J. Cardiol.98 ( 9 ), 1144 – 1149 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Verma A , MerisA, SkaliHet al. Prognostic implications of left ventricular mass and geometry following myocardial infarction: the VALIANT echocardiographic study . JACC Cardiovasc. Imaging1 ( 5 ), 582 – 591 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Christman KL , LeeRJ . Biomaterials for the treatment of myocardial infarction . J. Am. Coll. Cardiol.48 ( 5 ), 907 – 913 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Davis ME , MotionJP, NarmonevaDAet al. Injectabe self-assembling peptide nanofibers create intramyocardial microenvironments for endothelial celle . Circulation111 ( 4 ), 442 – 450 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Tsur-Gang O , RuvinovE, LandaNet al. The effects of peptide-based modification of aginate on left ventricular remodeling and function after myocardial infarction . Biomaterials30 ( 2 ), 189 – 195 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Landa N , MillerL, FeinbergMSet al. Effect of injectable alginate implant on cardiac remodeling and function after recent and old infarcts in rat . Circulation117 ( 11 ), 1388 – 1396 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Leor J , TuviaS, GuettaVet al. Intracoronary injection of in situ forming alginate hydrogel reverses left ventricular remodeling after myocardial infarction in swine . J. Am Coll. Cardiol.54 ( 11 ), 1014 – 1023 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Frey N , LinkeA, SüselbeckTet al. Intracoronary delivery of injectable bioabsorbable scaffold (IK-5001) to treat left ventricular remodeling after ST-elevation myocardial infarction: a first-in-man study . Circ. Cardiovasc. Interv.7 ( 6 ), 806 – 812 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Rao SV , ZeymerU, DouglasPSet al. Bioabsorbable intracoronary matrix for prevention of ventricular remodeling after myocardial infarction . J. Am. Coll. Cardiol.68 ( 7 ), 715 – 723 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Lee RJ , HinsonA, BauernschmittRet al. The feasibility and safety of Algisyl-LVR™ as a method of left ventricular augmentation in patients with dilated cardiomyopathy: initial first in man clinical results . Int. J. Cardiol.199, 18 – 24 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Marso SP , DanielsGH, Brown-FrandsenKet al. Liraglutide and cardiovascular outcome in Type 2 diabetes . N. Engl. J. Med.375 ( 4 ), 311 – 322 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Chen WR , ChenYD, TianFet al. Effects of liraglutide on reperfusion injury in patients with ST-segment–elevation myocardial infarction . Circ. Cardiovasc. Imaging9 ( 12 ), e005146 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Chen WR , HuSY, ChenYDet al. Effects of liraglutide on left ventricular function in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention . Am. Heart J.170 ( 5 ), 845 – 854 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Sumi S , KobayashiH, YasudaSet al. Postconditioning effect of granulocyte colony-stimulating factor is mediated through activation of risk pathway and opening of the mitochondrial KATP channels . Am. J. Physiol. Heart Circ. Physiol.299 ( 4 ), H1174 – H11782 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Achilli F , MalafronteC, MaggioliniSet al. G-CSF treatment for STEMI: final 3-year follow-up of the randomised placebo-controlled STEM-AMI trial . Heart100 ( 7 ), 574 – 581 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Achilli F , MalafronteC, CesanaFet al. Granulocyte-colony stimulating factor for large anterior ST-elevation myocardial infarction: rationale and design of the prospective randomized Phase III STEM-AMI OUTCOME trial . Am. Heart J.170 ( 4 ), 652 – 658 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Dixit P , KatareR . Challenges in identifying the best source of stem cells for cardiac regeneration therapy . Stem Cell Res. Ther.6, 26 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Beltrami AP , UrbanekK, KajsturaJet al. Evidence that human cardiac myocytes divide after myocardial infarction . N. Engl. J. Med.344 ( 23 ), 1750 – 1757 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• Beltrami AP , BarlucchiL, TorellaDet al. Adult cardiac stem cells are multipotent and support myocardial regeneration . Cell114 ( 6 ), 763 – 766 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Bergmann O , BhardwajRD, BernardSet al. Evidence for cardiomyocyte renewal in humans . Science324 ( 5923 ), 98 – 102 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Strauer BE , BrehmM, ZeusTet al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans . Circulation106 ( 15 ), 1913 – 1918 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Schächinger V , ErbsS, ElsässerAet al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction . N. Engl. J. Med.355, 1210 – 1221 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Assmus B , LeistnerDM, SchächingerVet al. Long-term clinical outcome after intracoronary application of bone marrow-derived mononuclear cells for acute myocardial infarction: migratory capacity of administered cells determines event-free survival . Eur. Heart J.35 ( 19 ), 1275 – 1283 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Dill T , SchächingerV, RolfAet al. Intracoronary administration of bone marrow-derived progenitor cells improves left ventricular function in patients at risk for adverse remodeling after acute ST-segment elevation myocardial infarction: results of the reinfusion of enriched progenitor cells and infarct remodeling in acute myocardial infarction study (REPAIR-AMI) cardiac magnetic resonance imaging substudy . Am. Heart J.157 ( 3 ), 541 – 547 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Delewi R , HirschA, TijssenJGet al. Impact of intracoronary bone marrow cell therapy on left ventricular function in the setting of ST-segment elevation myocardial infarction: a collaborative meta analysis . Eur. Heart J.35 ( 15 ), 989 – 998 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Gyöngyösi M , WojakowskiW, LemarchandPet al. Meta-Analysis of Cell-based CaRdiac stUdiEs (ACCRUE) in patients with acute myocardial infarction based on individual patient data . Circ. Res.116 ( 8 ), 1346 – 1360 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Wöhrle J , von ScheidtF, SchauweckerPet al. Impact of cell number and microvascular obstruction in patients with bone-marrow derived cell therapy: final results from the randomized, double-blind, placebo controlled intracoronary Stem Cell therapy in patients with Acute Myocardial Infarction (SCAMI) trial . Clin. Res. Cardiol.102 ( 10 ), 765 – 770 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Surder D , MankaR, MoccettiTet al. Effect of bone marrow-derived mononuclear cell treatment, early or late after acute myocardial infarction: 12 months CMR and long-term clinical results . Circ. Res.119 ( 3 ), 481 – 490 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Traverse JH , HenryTD, EllisSGet al. Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial . JAMA306 ( 19 ), 2110 – 2119 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Roncalli J , MouquetF, PiotCet al. Intracoronary autologous mononucleated bone marrow cell infusion for acute myocardial infarction: results of the randomized multicenter BONAMI trial . Eur. Heart J.32 ( 14 ), 1748 – 1757 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Lamirault G , SusenS, ForestVet al. Difference in mobilization of progenitor cells after myocardial infarction in smoking versus non-smoking patients: insights from the BONAMI trial . Stem Cell Res. Ther.4 ( 6 ), 152 ( 2013 ).
   PubMedGoogle Scholar
• Mayfield AE , FitzpatrickME, LathamNet al. The impact of patient co-morbidities on the regenerative capacity of cardiac explant-derived stem cells . Stem Cell Res. Ther.7 ( 1 ), 60 ( 2016 ).
   PubMedGoogle Scholar
• Assmus B , HonoldJ, SchachingerVet al. Transcoronary transplantation of autologous CD34+ stem cells after myocardial infarction . N. Engl. J. Med.355 ( 12 ), 1222 – 1232 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Schachinger V , ErbsS, ElsasserAet al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction . N. Engl. J. Med.355 ( 12 ), 1210 – 1221 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Lorsodo DW , SchatzRA, WhiteCJet al. Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a Phase I/IIa double-blind, randomized controlled trial . Circulation115 ( 25 ), 3165 – 3172 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Tendera M , WojakowskiW, RuzyłłoWet al. Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre myocardial regeneration by intracoronary infusion of selected population of stem cells in acute myocardial infarction (REGENT) trial . Eur. Heart J.30 ( 11 ), 1313 – 1321 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Quyyumi AA , WallerEK, MurrowJet al. CD34(+) cell infusion after ST elevation myocardial infarction is associated with improved perfusion and is dose dependent . Am. Heart J.161 ( 1 ), 98 – 105 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Quyyumi AA , VasquezA, KereiakesDJet al. PreSERVE-AMI: a randomized, double-blind, placebo-controlled clinical trial of intracoronary administration of autologous CD34+ cells in patients with left ventricular dysfunction post STEMI . Circ. Res.120 ( 2 ), 324 – 331 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• Chen SL , FangWW, YeFet al. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction . Am. J. Cardiol.94 ( 1 ), 92 – 95 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Hare JM , TraverseJH, HenryTDet al. A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction . J. Am. Coll. Cardiol.54 ( 24 ), 2277 – 2286 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Wang ZI , WangL, SuXet al. Rational transplant timing and dose of mesenchymal stromal cells in patients with acute myocardial infarction: a meta-analysis of randomized controlled trials . Stem Cell Res. Ther.8 ( 1 ), 21 ( 2017 ).
   PubMedGoogle Scholar
• Luger D , LipinskiMJ, WestmanPCet al. Intravenously-delivered mesenchymal stem cells: systemic anti-inflammatory effects improve left ventricular dysfunction in acute myocardial infarction and ischemic cardiomyopathy . Circ. Res.120 ( 10 ), 1598 – 1613 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• Luo L , TangJ, NishiKet al. Fabrication of synthetic mesenchymal stem cells for the treatment of acute myocardial infarction in mice . Circ. Res.120 ( 11 ), 1768 – 1775 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• Wei K , SerpooshanV, HurtadoCet al. Epicardial FSTL1 reconstitution regenerates the adult mammalian heart . Nature525 ( 7570 ), 479 – 485 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Molofsky AV , PardalR, IwashitaT, ParkIK, ClarkeMF, MorrisonSJ . Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation . Nature425 ( 6961 ), 962 – 967 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Valiente-Alandi I , Albo-CastellanosC, HerreroDet al. Cardiac Bmi1(+) cells contribute to myocardial renewal in the murine adult heart . Stem Cell Res. Ther.6, 205 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Valiente-Alandi I , Albo-CastellanosC, HerreroD, SanchezI, BernadA . Bmi1+ cardiac progenitor cells contribute to myocardial repair following acute injury . Stem Cell Res. Ther.7 ( 1 ), 100 ( 2016 ).
   PubMedGoogle Scholar
• Pandey R , AhmedRP . MicroRNAs inducing proliferation of quiescent adult cardiomyocytes . Cardiovasc. Regen. Med.2 ( 1 ), e519 ( 2015 ).
   PubMedGoogle Scholar
• Lee SH , HongJH, ChoKH, NohJW, ChoHJ . Discrepancy between short-term and long-term effects of bone marrow-derived cell therapy in acute myocardial infarction: a systematic review and meta-analysis . Stem Cell Res. Ther.7 ( 1 ), 153 ( 2016 ).
   PubMedGoogle Scholar